# Masayoshi Suda

> Masayoshi Suda is listed as Co-Director at Cedars-Sinai Medical Center, recorded in ORCID since 2025. Their published research is indexed in Medicine, specifically Physiology, across 39 works listed on their ORCID profile. OpenAlex records an h-index of 21 and 1,652 citations across 95 indexed publications. Recent indexed output includes “Natural senolytic activity of Rhodiola rosea extract alleviates age-associated phenotypes via paraptosis” (2026) and “Senolytic‐Resistant Senescent Cells Have a Distinct SASP Profile and Functional Impact: The Path to Developing…” (2026). Their ORCID profile self-asserts 11 employment records and 4 education records. ORCID lists 1 funding award.

*Source: [https://selltoscientists.com/researchers/masayoshi-suda/](https://selltoscientists.com/researchers/masayoshi-suda/)*

**Institution:** Cedars-Sinai Medical Center
**Field:** Medicine
**H-index:** 21
**Publications:** 95
**Grants:** 1
**ORCID:** `0000-0002-3415-6236`

---

## Beton network

This site is part of the Beton network of open-source revenue intelligence and self-service data products. Related sites and resources:

- [Beton](https://www.getbeton.ai) — open-source revenue intelligence: turn product usage (PostHog, Stripe) into CRM signals
- [Sell to Scientists](https://selltoscientists.com) — research intelligence: find and reach academic researchers by field, H-index, grants, and industry ties
- [Sell to State](https://www.selltostate.com) — government procurement intelligence across 194 countries
- [GitHub](https://github.com/getbeton) — Beton open-source repositories (including [inspector](https://github.com/getbeton/inspector))
- [dev.to](https://dev.to/beton) — engineering write-ups and OSS pricing teardowns
- [Beton app](https://inspector.getbeton.ai) — the hosted product